Ascites pathophysiology

Jump to navigation Jump to search

Ascites Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ascites from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ascites pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ascites pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ascites pathophysiology

CDC on Ascites pathophysiology

Ascites pathophysiology in the news

Blogs on Ascites pathophysiology

Directions to Hospitals Treating Ascites

Risk calculators and risk factors for Ascites pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Eiman Ghaffarpasand, M.D. [2]

Overview

Pathophysiology

Pathogenesis

  • Ascites is excess accumulation of fluid in the peritoneal cavity. The fluid can be defined as a transudate or an exudate. Amounts of up to 25 liters are fully possible.[1]
  • Roughly, transudates are a result of increased pressure in the portal vein (>8 mmHg), such as cirrhosis; while exudates are actively secreted fluid due to inflammation or malignancy.
  • Exudates:
  • Transudates:
    • Low protein (< 30 g/L)
    • Low lactate dehydrogenase (LDH)
    • High pH
    • Normal glucose
    • Fewer than 1 white cell per 1000 mm³

Serum Albumin Ascites Gradiant (SAAG)

  • The most useful measure is the difference between ascitic and serum albumin concentrations.
  • A difference of less than 1.1 g/dl (10 g/L) implies an exudate.

Cirrhotic Ascites

  • The main pathophysiology of ascites in cirrhotic patients consists of three interrelated mechanisms, include:[2]
    • Portal hypertension
    • Vasodilation
    • Hyperaldosteronism
  • There is a nitric oxide overload in cirrhotic patients from an unknown source. Therefore, they involved in hypovolemia secondary to the systemic vasodilation.[3]
  • The visodialtion induced by nitric oxide would trigger the stimulation of juxta-glumerular system to upregulate antidiuretic hormone (ADH) and sympathetic drive.[4] Excess ADH causes water retention and volume overload.[5]
  • Despite the normal physiology of vessels, angiotensin would not cause vasoconstriction in cirrhotic patients and vasodilation becomes perpetuated.[6]
  • Portal hypertension leads to more production of lymph, to the extend of lymphatic system overload. Then, the lymphatic overflow will directed into to peritoneal cavity, forming ascites.[7]

Non-Cirrhotic Ascites

  • Peritoneal malignancy produces some protein factors into the peritoneum, which may lead to osmotic drainage of water and fluid accumulation. Tuberculosis and other forms of ascites are induced through the same mechanism and osmotic fluid shift.[8]
  • Pancreatic and biliary ascites are induced through leakage of pancreatic secretions or bile into the peritoneal cavity, which may lead to inflammatory fluid shift and accumulation.



 
 
Renin-angiotensin system
 
 
Sympathetic nervous system
 
 
Antidiuretic hormone
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Systemic circulation
 
 
 
Renal circulation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Arterial vasoconstriction
 
↑Tubular Na and H2O reabsorbtion
 
Renal vasoconstriction
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Arterial hypertension
 
Na and H2O excretion
 
Hepatorenal syndrome
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fluid overload
 
 
 
 
Dilutional hyponatremia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ascites formation
 
 
 
 
 
 


Genetics

  • There is no genetic background for ascites.
  • Ascites syndrome, also called pulmonary hypertension, is in fact a genetic disorder in broilers and poultry.[9]

Associated Conditions

Associated conditions with ascites are as following:[10]

  • Cirrhosis
  • Heart failure
  • Portal hypertension
  • Kwashiorkor
  • Viral hepatitis
  • Pancreatic disease
  • Biliary disease

Gross Pathology

  • On gross pathology, clear to pale yellow fluid accumulation in peritoneal space are characteristic findings of ascites under normal condition.[11]

Chylous ascites

  • Chylous ascites gross pathology is milky presentation of ascites fluid, which is reflective of high amounts of chylomicrons.[12]
  • On gross pathology, milky appearance of ascitic fluid is characteristics of the followings:[13]
    • Cirrhosis
    • Infections (parasitic and tuberculosis)
    • Malignancy
    • Congenital defects
    • Traumatism
    • Inflammatory processes
    • Nephropathies
    • Cardiopathies

Pseudochylous ascites

  • Pseudochylous is the condition in which on gross pathology the ascitic fluid appearance is cloudy and/or turbid.
  • The following conditions can lead to pseudochylous:[14]
    • Bacterial infection
    • Peritonitis, pancreatitis
    • Perforated bowel

Bloody ascites

  • On gross pathology, bloody appearance of ascitic fluid is characteristics of the followings:[15]
    • Benign or malignant tumors
    • Hemorrhagic pancreatitis
    • Perforated ulcer

Microscopic Pathology

Cirrhosis with bridging fibrosis (yellow arrow) and nodule (black arrow) - By Nephron, via Librepathology.org[16]
  • On microscopic histopathological analysis, characteristic findings of cirrhosis, as the most common cause of ascites, are based on Robbins definition (all three is needed for diagnosis):[17]







References

  1. Runyon BA (2009). "Management of adult patients with ascites due to cirrhosis: an update". Hepatology. 49 (6): 2087–107. doi:10.1002/hep.22853. PMID 19475696.
  2. Giefer, Matthew J; Murray, Karen F; Colletti, Richard B (2011). "Pathophysiology, Diagnosis, and Management of Pediatric Ascites". Journal of Pediatric Gastroenterology and Nutrition. 52 (5): 503–513. doi:10.1097/MPG.0b013e318213f9f6. ISSN 0277-2116.
  3. La Villa, Giorgio; Gentilini, Paolo (2008). "Hemodynamic alterations in liver cirrhosis". Molecular Aspects of Medicine. 29 (1–2): 112–118. doi:10.1016/j.mam.2007.09.010. ISSN 0098-2997.
  4. Leiva JG, Salgado JM, Estradas J, Torre A, Uribe M (2007). "Pathophysiology of ascites and dilutional hyponatremia: contemporary use of aquaretic agents". Ann Hepatol. 6 (4): 214–21. PMID 18007550.
  5. Bichet, Daniel (1982). "Role of Vasopressin in Abnormal Water Excretion in Cirrhotic Patients". Annals of Internal Medicine. 96 (4): 413. doi:10.7326/0003-4819-96-4-413. ISSN 0003-4819.
  6. Hennenberg, M.; Trebicka, J.; Kohistani, A. Z.; Heller, J.; Sauerbruch, T. (2009). "Vascular hyporesponsiveness to angiotensin II in rats with CCl4-induced liver cirrhosis". European Journal of Clinical Investigation. 39 (10): 906–913. doi:10.1111/j.1365-2362.2009.02181.x. ISSN 0014-2972.
  7. Laine GA, Hall JT, Laine SH, Granger J (1979). "Transsinusoidal fluid dynamics in canine liver during venous hypertension". Circ. Res. 45 (3): 317–23. PMID 572270.
  8. Goodman GM, Gourley GR (1988). "Ascites complicating ventriculoperitoneal shunts". J. Pediatr. Gastroenterol. Nutr. 7 (5): 780–2. PMID 3054040.
  9. Pakdel, A.; van Arendonk, J.A.M.; Vereijken, A.L.J.; Bovenhuis, H. (2010). "Genetic parameters of ascites-related traits in broilers: effect of cold and normal temperature conditions". British Poultry Science. 46 (1): 35–42. doi:10.1080/00071660400023938. ISSN 0007-1668.
  10. Moore KP, Aithal GP (2006). "Guidelines on the management of ascites in cirrhosis". Gut. 55 Suppl 6: vi1–12. doi:10.1136/gut.2006.099580. PMC 1860002. PMID 16966752.
  11. Huang LL, Xia HH, Zhu SL (2014). "Ascitic Fluid Analysis in the Differential Diagnosis of Ascites: Focus on Cirrhotic Ascites". J Clin Transl Hepatol. 2 (1): 58–64. doi:10.14218/JCTH.2013.00010. PMC 4521252. PMID 26357618.
  12. Fukunaga, Naoto; Shomura, Yu; Nasu, Michihiro; Okada, Yukikatsu (2011). "Chylous Ascites as a Rare Complication After Abdominal Aortic Aneurysm Surgery". Southern Medical Journal. 104 (5): 365–367. doi:10.1097/SMJ.0b013e3182142b7d. ISSN 0038-4348.
  13. Tarn, A. C.; Lapworth, R. (2010). "Biochemical analysis of ascitic (peritoneal) fluid: what should we measure?". Annals of Clinical Biochemistry. 47 (5): 397–407. doi:10.1258/acb.2010.010048. ISSN 0004-5632.
  14. Runyon BA, Akriviadis EA, Keyser AJ (1991). "The opacity of portal hypertension-related ascites correlates with the fluid's triglyceride concentration". Am. J. Clin. Pathol. 96 (1): 142–3. PMID 2069132.
  15. Runyon BA, Hoefs JC, Morgan TR (1988). "Ascitic fluid analysis in malignancy-related ascites". Hepatology. 8 (5): 1104–9. PMID 3417231.
  16. "File:Cirrhosis high mag.jpg - Libre Pathology".
  17. Mitchell, Richard (2012). Pocket companion to Robbins and Cotran pathologic basis of disease. Philadelphia, PA: Elsevier Saunders. ISBN 978-1416054542.

Template:WH Template:WS